{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:18:40Z","timestamp":1790245120130,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T00:00:00Z","timestamp":1324425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00228-011-1184-3","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T08:02:57Z","timestamp":1324368177000},"page":"821-832","source":"Crossref","is-referenced-by-count":63,"title":["Drug-induced immune thrombocytopaenia: results from the Berlin Case\u2013Control Surveillance Study"],"prefix":"10.1007","volume":"68","author":[{"given":"Edeltraut","family":"Garbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Andersohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bronder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulgabar","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Klimpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thomae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Sp\u00e4th-Schwalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gr\u00fcneisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanife","family":"Kurtal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,21]]},"reference":[{"issue":"6","key":"1184_CR1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra066469","volume":"357","author":"RH Aster","year":"2007","unstructured":"Aster RH, Bougie DW (2007) Drug-induced immune thrombocytopenia. N Engl J Med 357(6):580\u2013587","journal-title":"N Engl J Med"},{"issue":"2","key":"1184_CR2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5858\/133.2.309","volume":"133","author":"B Kenney","year":"2009","unstructured":"Kenney B, Stack G (2009) Drug-induced thrombocytopenia. Arch Pathol Lab Med 133(2):309\u2013314","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"1184_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10072-009-0187-7","volume":"31","author":"SY Kang","year":"2010","unstructured":"Kang SY, Choi JC, Kang JH, Lee JS (2010) Acute subdural hemorrhage associated with rifampicin-induced thrombocytopenia. Neurol Sci 31(2):199\u2013200","journal-title":"Neurol Sci"},{"issue":"4","key":"1184_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1227\/00006123-198610000-00023","volume":"19","author":"VR Kolluri","year":"1986","unstructured":"Kolluri VR, Reddy DR, Reddy PK, Naidu MR, Kumari CS (1986) Subdural hematoma secondary to immune thrombocytopenic purpura: case report. Neurosurgery 19(4):635\u2013636","journal-title":"Neurosurgery"},{"key":"1184_CR5","unstructured":"Single report database for drug\u2013induced thrombocytopenia: An update. http:\/\/www.ouhsc.edu\/platelets\/InternetPostingLitSingleFrames2_18_11.htm . Accessed 13 September 2011"},{"key":"1184_CR6","unstructured":"George JN, Aster RH (2009) Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematol Am Soc Hematol Educ Program:153\u2013158"},{"issue":"4","key":"1184_CR7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.hoc.2007.06.005","volume":"21","author":"GP Visentin","year":"2007","unstructured":"Visentin GP, Liu CY (2007) Drug-induced thrombocytopenia. Hematol Oncol Clin North Am 21(4):685\u2013696, vi","journal-title":"Hematol Oncol Clin North Am"},{"issue":"15","key":"1184_CR8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2165\/00002018-200427150-00007","volume":"27","author":"PM Bemt van den","year":"2004","unstructured":"Van den Bemt PM, Meyboom RH, Egberts AC (2004) Drug-induced immune thrombocytopenia. Drug Saf 27(15):1243\u20131252","journal-title":"Drug Saf"},{"key":"1184_CR9","unstructured":"Database for drug\u2013induced thrombocytopenia from Group Patient Reports: an update. http:\/\/www.ouhsc.edu\/platelets\/InternetPostingLitGroup2_18_11.htm . Accessed 13 September 2011"},{"issue":"11","key":"1184_CR10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","volume":"129","author":"JN George","year":"1998","unstructured":"George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T (1998) Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 129(11):886\u2013890","journal-title":"Ann Intern Med"},{"issue":"6","key":"1184_CR11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1538-7836.2009.03360.x","volume":"7","author":"RH Aster","year":"2009","unstructured":"Aster RH, Curtis BR, McFarland JG, Bougie DW (2009) Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 7(6):911\u2013918","journal-title":"J Thromb Haemost"},{"issue":"12","key":"1184_CR12","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2010-03-276691","volume":"116","author":"JA Reese","year":"2010","unstructured":"Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK (2010) Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood 116(12):2127\u20132133","journal-title":"Blood"},{"issue":"12","key":"1184_CR13","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood-2010-06-291484","volume":"116","author":"TE Warkentin","year":"2010","unstructured":"Warkentin TE, Anderson JA (2010) DITP causation: 3 methods better than 1? Blood 116(12):2002\u20132003","journal-title":"Blood"},{"issue":"9","key":"1184_CR14","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1182\/blood.V82.9.2714.2714","volume":"82","author":"DW Kaufman","year":"1993","unstructured":"Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, Shapiro S (1993) Acute thrombocytopenic purpura in relation to the use of drugs. Blood 82(9):2714\u20132718","journal-title":"Blood"},{"issue":"8","key":"1184_CR15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00002018-200629080-00008","volume":"29","author":"MJ Berg ten","year":"2006","unstructured":"ten Berg MJ, Huisman A, Souverein PC, Schobben AF, Egberts AC, van Solinge WW, van den Bemt PM (2006) Drug-induced thrombocytopenia: a population study. Drug Saf 29(8):713\u2013721","journal-title":"Drug Saf"},{"issue":"1","key":"1184_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/11530350-000000000-00000","volume":"33","author":"F Bertuola","year":"2010","unstructured":"Bertuola F, Morando C, Menniti-Ippolito F, Da Cas R, Capuano A, Perilongo G, Da Dalt L (2010) Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case\u2013control study in Italy. Drug Saf 33(1):65\u201372","journal-title":"Drug Saf"},{"issue":"3","key":"1184_CR17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ajh.20176","volume":"77","author":"F Andersohn","year":"2004","unstructured":"Andersohn F, Bronder E, Klimpel A, Garbe E (2004) Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case\u2013control Surveillance Study. Am J Hematol 77(3):316\u2013318","journal-title":"Am J Hematol"},{"issue":"1","key":"1184_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","volume":"88","author":"JN George","year":"1996","unstructured":"George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88(1):3\u201340","journal-title":"Blood"},{"key":"1184_CR19","unstructured":"The Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. http:\/\/www.who-umc.org\/Graphics\/24734.pdf . Accessed 13 September 2011"},{"key":"1184_CR20","unstructured":"World Health Organization. The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC\/DDD). http:\/\/www.who.int\/classifications\/atcddd\/en\/ . Accessed 13 September 2011"},{"issue":"6","key":"1184_CR21","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","volume":"70","author":"V Kiefel","year":"1987","unstructured":"Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C (1987) Monoclonal antibody\u2013specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 70(6):1722\u20131726","journal-title":"Blood"},{"issue":"3","key":"1184_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-3148.1992.tb00153.x","volume":"2","author":"V Kiefel","year":"1992","unstructured":"Kiefel V (1992) The MAIPA assay and its applications in immunohaematology. Transfus Med 2(3):181\u2013188","journal-title":"Transfus Med"},{"issue":"5","key":"1184_CR23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1537-2995.1999.39050527.x","volume":"39","author":"O Meyer","year":"1999","unstructured":"Meyer O, Gaedicke G, Salama A (1999) Demonstration of drug-dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor. Transfusion 39(5):527\u2013530","journal-title":"Transfusion"},{"key":"1184_CR24","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-01080-4","volume-title":"Arzneiverordnungsreport 2009","author":"U Schwabe","year":"2009","unstructured":"Schwabe U, Paffrath D (2009) Arzneiverordnungsreport 2009. Springer Medizin Verlag, Heidelberg"},{"issue":"2","key":"1184_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00392-006-0459-7","volume":"96","author":"SM Said","year":"2007","unstructured":"Said SM, Hahn J, Schleyer E, Muller M, Fiedler GM, Buerke M, Prondzinsky R (2007) Glycoprotein IIb\/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment. Clin Res Cardiol 96(2):61\u201369","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"1184_CR26","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood.V99.6.2054","volume":"99","author":"BR Curtis","year":"2002","unstructured":"Curtis BR, Swyers J, Divgi A, McFarland JG, Aster RH (2002) Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets. Blood 99(6):2054\u20132059","journal-title":"Blood"},{"issue":"3","key":"1184_CR27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1096-8652(199907)61:3<205::AID-AJH8>3.0.CO;2-9","volume":"61","author":"SJ Jubelirer","year":"1999","unstructured":"Jubelirer SJ, Koenig BA, Bates MC (1999) Acute profound thrombocytopenia following C7E3 Fab (Abciximab) therapy: case reports, review of the literature and implications for therapy. Am J Hematol 61(3):205\u2013208","journal-title":"Am J Hematol"},{"issue":"2","key":"1184_CR28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1522-726X(200002)49:2<177::AID-CCD13>3.0.CO;2-J","volume":"49","author":"B Vahdat","year":"2000","unstructured":"Vahdat B, Canavy I, Fourcade L, Garcia E, Quilici J, Bonnet JL, Bory M (2000) Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment. Catheter Cardiovasc Interv 49(2):177\u2013180","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"1184_CR29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1345\/aph.1E244","volume":"39","author":"JC Coons","year":"2005","unstructured":"Coons JC, Barcelona RA, Freedy T, Hagerty MF (2005) Eptifibatide-associated acute, profound thrombocytopenia. Ann Pharmacother 39(2):368\u2013372","journal-title":"Ann Pharmacother"},{"issue":"6","key":"1184_CR30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1538-7836.2004.00744.x","volume":"2","author":"BR Curtis","year":"2004","unstructured":"Curtis BR, Divgi A, Garritty M, Aster RH (2004) Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. J Thromb Haemost 2(6):985\u2013992","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1184_CR31","first-page":"820","volume":"92","author":"P Nurden","year":"2004","unstructured":"Nurden P, Clofent-Sanchez G, Jais C, Bermejo E, Leroux L, Coste P, Nurden AT (2004) Delayed immunologic thrombocytopenia induced by abciximab. Thromb Haemost 92(4):820\u2013828","journal-title":"Thromb Haemost"},{"issue":"1","key":"1184_CR32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5694\/j.1326-5377.1978.tb131300.x","volume":"2","author":"HG Dickson","year":"1978","unstructured":"Dickson HG (1978) Trimethoprim-sulphamethoxazole and thrombocytopenia. Med J Aust 2(1):5\u20137","journal-title":"Med J Aust"},{"issue":"4","key":"1184_CR33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2796.1990.tb00245.x","volume":"228","author":"M Keisu","year":"1990","unstructured":"Keisu M, Wiholm BE, Palmblad J (1990) Trimethoprim-sulphamethoxazole-associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting system. J Intern Med 228(4):353\u2013360","journal-title":"J Intern Med"},{"issue":"2","key":"1184_CR34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.aje.a113189","volume":"114","author":"KJ Rothman","year":"1981","unstructured":"Rothman KJ (1981) Induction and latent periods. Am J Epidemiol 114(2):253\u2013259","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1184_CR35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.21307\/immunohematology-2019-640","volume":"15","author":"MF Leach","year":"1999","unstructured":"Leach MF, Aubuchon JP (1999) Frequency of thrombocytopenia associated with gentamicin therapy. Immunohematology 15(4):167\u2013170","journal-title":"Immunohematology"},{"issue":"9396","key":"1184_CR36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","volume":"362","author":"DC Wraith","year":"2003","unstructured":"Wraith DC, Goldman M, Lambert PH (2003) Vaccination and autoimmune disease: what is the evidence? Lancet 362(9396):1659\u20131666","journal-title":"Lancet"},{"issue":"2","key":"1184_CR37","first-page":"119","volume":"22","author":"T Jadavji","year":"2003","unstructured":"Jadavji T, Scheifele D, Halperin S (2003) Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J 22(2):119\u2013122","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"1184_CR38","first-page":"417","volume":"9","author":"P Casoli","year":"1989","unstructured":"Casoli P, Tumiati B (1989) Acute idiopathic thrombocytopenic purpura after anti-influenza vaccination. Medicina (Firenze) 9(4):417\u2013418","journal-title":"Medicina (Firenze)"},{"issue":"4","key":"1184_CR39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.bmt.1705442","volume":"38","author":"K Ikegame","year":"2006","unstructured":"Ikegame K, Kaida K, Fujioka T, Kawakami M, Hasei H, Inoue T, Taniguchi Y, Yoshihara S, Hayashi S, Kurata Y, Ogawa H (2006) Idiopathic thrombocytopenic purpura after influenza vaccination in a bone marrow transplantation recipient. Bone Marrow Transplant 38(4):323\u2013324","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"1184_CR40","first-page":"322","volume":"8","author":"M Tishler","year":"2006","unstructured":"Tishler M, Levy O, Amit-Vazina M (2006) Immune thrombocytopenic purpura following influenza vaccination. Isr Med Assoc J 8(5):322\u2013323","journal-title":"Isr Med Assoc J"},{"key":"1184_CR41","first-page":"628","volume":"114","author":"K Wagner","year":"1964","unstructured":"Wagner K (1964) Protrahierte Thrombozytopenie nach Polymyelitis Schutzimpfung. Wien Med Wochenschr 114:628\u2013631","journal-title":"Wien Med Wochenschr"},{"issue":"14","key":"1184_CR42","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.292.14.1702","volume":"292","author":"RP Wise","year":"2004","unstructured":"Wise RP, Iskander J, Pratt RD, Campbell S, Ball R, Pless RP, Braun MM (2004) Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA 292(14):1702\u20131710","journal-title":"JAMA"},{"issue":"1","key":"1184_CR43","first-page":"49","volume":"15","author":"E Altintas","year":"2004","unstructured":"Altintas E, Oguz D, Kacar S, Ozderin Y, Sezgin O, Zengin NI (2004) Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia. Turk J Gastroenterol 15(1):49\u201352","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"1184_CR44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00004836-200207000-00023","volume":"35","author":"S Kacar","year":"2002","unstructured":"Kacar S, Akdogan M, Kosar Y, Parlak E, Sasmaz N, Oguz P, Aydog G (2002) Estrogen and cyproterone acetate combination-induced autoimmune hepatitis. J Clin Gastroenterol 35(1):98\u2013100","journal-title":"J Clin Gastroenterol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1184-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1184-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1184-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T03:27:02Z","timestamp":1640057222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1184-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,21]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1184-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,21]]}}}